We conducted a prospective study of anticardiolipin antibody (aCL) testing, performed in our university hospital. Among 6321 consecutive patients tested for both IgG and IgM aCL, 91 patients with medium or high positivity (>99th percentile) had a subsequent confirmatory test. Among them, 53 had a persistent positivity at 12 weeks. In this real world setting, patients with transient positivity had lower values than patients with persistent positivity.
WilsonWAGharaviAEKoikeT. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum1999; 42: 1309–1311.
2.
MiyakisSLockshinMDAtsumiT. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost2006; 4: 295–306.
3.
GinsburgKSLiangMHNewcomerL. Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis. Ann Intern Med1992; 117: 997–1002.
4.
TincaniAAllegriFSanmarcoM. Anticardiolipin antibody assay: a methodological analysis for a better consensus in routine determinations - a cooperative project of the European Antiphospholipid Forum. Thromb Haemost2001; 86: 575–583.
5.
WahlDGuilleminFde MaistreEPerret-GuillaumeCLecompteTThibautG. A meta- analysis of the risk of venous thrombosis in individuals with antiphospholipid antibodies without underlying autoimmune disease or previous thrombosis. Lupus1998; 7: 15–22.
6.
OpatrnyLDavidMKahnSRShrierIReyE. Association between antiphospholipid antibodies and recurrent fetal loss in women without autoimmune disease: A metaanalysis. J Rheumatol2006; 33: 2214–2221.
7.
ZuilySRegnaultVSelton-SutyC. Increased risk for heart valve disease associated with antiphospholipid antibodies in systemic lupus erythematosus patients: Meta-analysis of echocardiographic studies. Circulation2011; 124: 215–224.
8.
RuffattiAOlivieriSTonelloM. Influence of different IgG anticardiolipin antibody cut-off valueson antiphospholipid syndrome classification. J Thromb Haemost2008; 6: 1693–1696.
9.
DevreeseKMJVan HoeckeFV. Anticardiolipin and anti-β2glycoprotein-I antibody cut-off values in the diagnosis of antiphospholipid syndrome: more than calculating the in-house 99th percentiles, even for new automated assays. Thromb Res2011; 128: 598–600.
